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Published studies of Hh (Hedgehog) signaling in the developing prostate have reported varying and
discrepant effects on epithelial proliferation, ductal morphogenesis and growth. We report here that
these differing observations accrue from stage-speciﬁc effects of Hh signaling in the developing prostate.
Using in vitro organ cultures of the E16 UGS and P1 prostate, we show that ectopic Hh pathway activation
stimulates epithelial proliferation prenatally, but inhibits epithelial proliferation postnatally. Extrapolat-
ing from previously published observations that Hh target gene expression is altered in the reactive
stroma of prostate cancer, we examined and found discordant regulation of a subset of target genes by
Hh signaling in the prenatal and postnatal prostate. Cell based studies and recombination assays show
that these changes are not simply attributable to the age of the mesenchyme or the epithelium, but more
likely reﬂect a complex regulation by the cellular microenvironment. To determine the in vivo relevance
of these observations, we examined the effect of transgenic activation of Hh signaling on epithelial
proliferation in the prenatal and postnatal prostate and conﬁrmed the operation of stage-speciﬁc effects.
These observations demonstrate stage-speciﬁc differences in the effect of Hh signaling on epithelial
proliferation in the developing prostate and suggest that these are a product of complex interactions
determined by the cellular microenvironment.
& 2013 Elsevier Inc. All rights reserved.Introduction
The male sex accessory gland prostate develops from the
urogenital sinus (UGS) and is located between the base of the
bladder and urethra. Its development has been widely studied
using rodents as models. Prostate development is initiated at E16/
E18 (E16 in mouse and E18 in rat), when solid prostatic buds
emerge from the UGE and invade into the surrounding mesench-
yme to form the prostatic ductal buds. These buds undergo
elongation, branching, cell differentiation and ductal canalization
and form the prostatic ducts of the ventral, dorsolateral and
anterior lobes of the adult prostate. The complex process of
prostate development is androgen dependent and involves
mesenchymal–epithelial interactions mediated by multiple signal-
ing pathways.
Hedgehog (Hh) signaling controls multiple cellular events
including patterning, proliferation and differentiation in a variety
of embryonic developmental processes. There are three Hh ligandsll rights reserved.
cal School,
2 CSC, 600 Highland Avenue,in mammals: Sonic hedgehog (shh), Indian Hedgehog (Ihh) and
Desert Hedgehog (dhh). All three ligands bind to the transmem-
brane receptor, Patched (Ptc). Binding of the Hh ligand to Ptc
relieves repression of another transmembrane protein, Smooth-
ened (Krstic et al., 1995), activates the Hh signal transduction
pathway and results in activation of the Gli zinc-ﬁnger family of
transcription factors and transcription of Hh target genes. Gli1 and
Ptc1 are two conserved target genes and increase in their expres-
sion is considered a reliable indicator of the pathway activation.
Of the two Hh ligands (Shh and Ihh), both expressed in the
developing prostate, Shh is the more abundant. Localization
studies showed that Shh is expressed in the prostate epithelial
ducts, concentrated in the ductal tips, while its functional genes
Gli1 and Ptc1 are expressed in the surrounding mesenchyme. This
pattern indicates paracrine signaling from the epithelium to the
mesenchyme. Gene analysis studies revealed that the expression
of Shh is most abundant from E16 to P1, which is a crucial window
for early prostatic duct formation, and then gradually decreases to
a very low level in the adult stage. This expression pattern suggests
a potential role of Hh signaling in regulation of early prostate
development. The very ﬁrst study using a polyclonal neutralizing
Shh antibody showed that treatment of the grafted E15.5 UGS with
neutralizing Shh antibody prevented formation of prostatic ducts
(Podlasek et al., 1999). This observation indicated Hh signaling is
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inhibition of Hh signaling by cyclopamine in E14 explants reduced
the ductal tips number and decreased cell proliferation in both
epithelium and mesenchyme (Lamm et al., 2002). Those observa-
tions support a stimulatory role of Hh signaling in controlling the
prostate morphogenesis, In contrast, Hh signaling was showed to
inhibit both ductal branching and cell proliferation in P2 rat
ventral prostate (VP) explants, suggest a negative regulation of
Hh signaling on prostate morphogenesis (Wang et al., 2003). These
authors found decreased epithelial proliferation and duct tips
when explants were cultured in the presence of exogenous Shh,
and a corresponding increase in cell proliferation and duct tips
when cultured in the presence of the Hh signaling inhibitor
cyclopamine. Further, when P2 VP was co-cultured with UGM
cells that overexpressed activated Gli1 or Smo, the effects on
ductal branching and proliferation were found to mimic the results
obtained with exogenous Shh ligand. Another study using rat P0
VP explants found a suppressive effect of Hh signaling on ductal
branching, but yielded inconsistent observations on epithelial cell
proliferation (Freestone et al., 2003). A later study found no effect
of either cyclopamine or Shh on duct tip number in cultured E16.5
mouse UGS explants (Berman et al., 2004).
We revisited the role of Hh signaling on early prostate devel-
opment, focusing on its inﬂuences on epithelial proliferation and
ductal branching. We utilized chemical inhibition of cultured
tissues, genetic activation of the Hh pathway in stromal cells
cultured together with tissues in vitro tissue and transgenic mice
with conditional activation of the Hh pathways to compare the
effects of paracrine signaling pre- and postnatal. These studies
showed that Hh signaling exerts unique stage-speciﬁc effects on
epithelial proliferation and prostatic ductal branching morphogen-
esis that correlated with stage-dependent changes in Hh target
gene regulation by Hh signaling.Materials and methods
Explant culture, primary mesenchymal cell culture and tissue
recombination
E16 and P1 UGS tissues were collected from C57Bl/6 mice
(Charles River) and then placed on Millicell-CM ﬁlters (Millipore)
suspended on serum-free medium with 10−8 M DHT and other
supplements as described before (Doles et al., 2006). The medium
was changed every other day. For the co-culture experiment, the
E16 and P1 UGS tissues were cultured together with the UGSM-2
cells infected with retrovirus that expressed GFP (green ﬂuores-
cent protein) and activated SmoM2 or Gli2 at a ratio of 1105
UGSM-2 cells per UGS tissue. Primary UGM cells were freshly
isolated from the mouse E16/P1 UGS mesenchyme as described.
Primary UGM cells were placed in cell culture dishes with
Dulbecco's modiﬁed Eagles' medium/F12 containing 10% fetal
bovine serum, allowing 1-week culture to reach the conﬂuence
before exposure to Shh. For the tissue recombination studies, the
mesenchymal–epithelium separations were done on the E18/P1
UGS of Sprague Dawley rats (Charles River) and E16/P1 UGS of
C57bl mice, as described. Basically, the UGS tissue was incubated
with 1% trypsin at 4 1C for 75 min, followed by mechanical
dissociation. The recombinants were constructed by wrapping
the mouse E16/P1 UGM around the rat E18/P1 UGE tube, placed
together on the tissue culture inserts, followed by 7 days incuba-
tion in the serum-free deﬁned media supplemented with
10−8 M DHT.
AZ75 (AstraZeneca) (a cyclopamine derivative that binds to
Smo as a speciﬁc inhibitor of Hh signaling) was dissolved in 95%
EtOH and used in concentration at 0.5 μM; Exogenous Shh (Curis)was dissolved in PBS/0.1% BSA and diluted in the culture media to
5 nM as the ﬁnal concentration.
Explants were photographed under the dissection microscope
(Zeiss, Diagnostic) to quantitate the number of ductal tips (Lamm
et al., 2001).Real-time RT-PCR gene analysis
RNA was harvested from cultured tissues and UGM cells with
RNeasy Mini kit (Qiagen, Valencia, CA) with optional DNase
digestion to eliminate DNA contamination, followed by reverse
transcription and real-time PCR as described before (Doles et al.,
2006). PCR primers used are the same as listed in the previous
study (Yu et al., 2009). Results were normalized to Glyceraldehyde
3-phosphate dehydrogenase (GAPDH) levels. All experiments were
performed in triplicate and reported differences were statistically
signiﬁcant (Po0.05; Student's t-test).Transgenic mice and genotyping
Smo.YFP mice were obtained from the Jackson Laboratory. Fsp1.
cre mice were obtained from Dr. Bhowmick (University of
Vanderbilt, Nashville, TN). Rosa26 reporter mice were provided
by Dr. Sun (University of Wisconsin—Madison, Madison, WI). DNA
was isolated from mouse tails and genotyped by PCR analysis
using the following primers:Fsp1.cre AGGTGTAGAGAAGGCACTTAGC (forward)
CTAATCGCCATCTTCCAGCAGG (reverse), 411 bpSmoM2.
YFPAAGTTCATCTGC ACCACCG (mutant forward)TCCTTGAAGAAGATGGTGCG (mutant
reverse),173 bp
CGTGATCTGCAACTCCAGTC (wild type forward)
GGAGCGGGAGAAATGGATATG (wild type reverse)
410 bpThe SmoM2.YFP:Fsp1.cre mutants are showing positive bands
with both cre and SmoM2.YFP mutants; the rest of the littermates
are considered as controls.BrdU incorporation and immunohistochemistry
To visualize the proliferation cells in the explants cultured
tissues, 5-bromo-2′-deoxyuridine (BrdU) labeling medium
(1:1000, Roche Applied Science) was added to the culture media
2 h before ﬁxing the tissues. In the transgenic mice model, BrdU
was injected into the dam (prenatal E18) or P10 mouse (10 μL
undiluted per gram body weight, i.p.) 1 h before euthanasia.
Explants or UGS tissues were collected and ﬁxed in 10% formalin,
followed by parafﬁn embedding and sectioning (5 μm/section) to
perform immunoﬂuorescence staining as described (Cook et al.,
2007). The following primary antibodies were applied: mouse anti-
BrdU (1:10, Roche Applied Science), rabbit anti-PanCk (1:50) and
rabbit anti-P63 ( 1:100, Santa Cruz). Sections were counterstained
with Hoechst, cover slipped and imaged by an Olympus model
BX51 ﬂuorescent microscope. To calculate the proliferation index,
10–15 digital images were randomly selected from each group. BrdU
positive cells, P63 or PanCk positive cells were counted in each
image and the proliferation index in the epithelium was obtained
by calculating the ratio of the BrdU labeled epithelial cells to the
total epithelial cells. For statistical comparisons, BrdU labeling index
was analyzed by two-tailed Student's t-test.
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Prostate tissues were collected and ﬁxed (37% formaldehyde,
50% glutaraldehyde (Sigma), 10% NP40 (Calbiochem) in PBS) for
30 min, followed by cyroprotection step with a 30% sucrose over-
night immersion. The processed tissues were then embedded in
the optimum cutting temperature (OCT) compound for sectioning,
Tissue sections were then incubated with X-gal reaction buffer
(2 mmol/L magnesium chloride (Sigma), 0.2% IGEPAL CA-630
(Sigma), 0.1% sodium deoxycholic acid (Calbiochem), 5 μM potas-
sium ferrocyandine, 5 μM potassium ferricyanide, 1 mg/mL X-gal
substrate (Fisher Scientiﬁc) in PBS) overnight in 37 1C water bath
protected from light. The X-gal stained tissue section was washed
in PBS, counterstained with fast-red nucleus staining, cover
slipped and imaged (Olympus, BX-41).Tissue microdissection
Ventral and dorsalateral lobes were removed from the P21
mutant and control littermates. Microdissection were performed asFig. 1. Chemical inhibition of Hh signaling exerts differential effects on ductal morphoge
were cultured 7Hh inhibitor AZ75 (0.5 μM). Images were taken on the seventh day of cu
images taken on the seventh day of culture. This revealed that culture in the presence of
tips in P1 prostate tissues (F). n¼4, Po0.05. Scale bar: 500 μM.previously described (Sugimura et al., 1986). Brieﬂy, each prostate
lobe was incubated in 1% collagenase for 5–10 min, and then was
microdissected into two dimensions with ﬁne forceps under the
microscope. Quantitation of ductal tips were performed as previously
described (Podlasek et al., 1997; Sugimura et al., 1986).Results
Differential effects of Hh signaling inhibition on prostate ductal
branching in explant culture
To compare the effect of Hh signaling on ductal budding and
branching morphogenesis of the prenatal and postnatal prostate,
we cultured the E16 UGS and P1 prostate in vitrowith testosterone
supplemented serum free media in the presence and absence of a
Hh inhibitor. The cultured tissues were examined daily and the
total number of duct tips counted by a blinded observer after
7 days in culture. We observed nothing to suggest a toxic effect of
AZ75. Blockade of Hh signaling by AZ75 was conﬁrmed by RT-PCRnesis in prenatal and postnatal explants. E16 UGS (A,B) and P1 prostate (C,D) tissues
lture. (E,F) Quantitative comparison of total duct tips. Duct tips were counted from
AZ75 decreased the number of tips in E16 UGS (E) while increasing the number of
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of the experiment. Comparison of the cultured E16 UGS revealed a
signiﬁcantly decreased number of duct tips in tissues cultured in
the presence of AZ75. This ﬁnding replicates our previously
published data that ductal budding in the E16 UGS was inhibited
by the plant-derived Hh inhibitor cyclopamine. By contrast, AZ75
signiﬁcantly increased the number of duct tips in the cultured P1
explants (Fig. 1). This ﬁnding is consistent with the reported
stimulation of branching morphogenesis in the postnatal rat
prostate reported by Wang et al. (2003).
Differential effect of activated paracrine Hh signaling on prostate
ductal proliferation in explant co-culture
In our previous study of Hh signaling in prostate development,
we observed that inhibition of ductal budding in the E16 UGS was
associated with an inhibition of epithelial proliferation (Lamm
et al., 2002). In contrast, the studies by Freestone and Wang
suggested that inhibition of Hh signaling actually increased
epithelial proliferation in the postnatal prostate (Freestone et al.,
2003; Wang et al., 2003). These observations suggest stage-
speciﬁc effects on epithelial proliferation that parallel the differ-
ential effects on ductal morphogenesis. Chemical inhibition of Hh
signaling could affect epithelial proliferation by blocking autocrineFig. 2. Co-Culture of E16/P1 tissues with UGSM-2 cells transfected with activated Gli2 (G
of Gli1 and Ptc1 in UGSM-2 cells transfected with Gli2 or Smo compared to cells transfe
Smo induced ligand-independent Hh pathway activation. (C,D) UGSM-2 cells (1105) tra
E16 or (E,F) P1 tissues (n¼3). Representative images were taken on the seventh day ofHh signaling, blocking paracrine signaling or blocking both. To
speciﬁcally examine the effect of paracrine Hh signaling on
epithelial proliferation in the prenatal and postnatal prostate we
performed co-culturing of the E16 UGS and P1 prostate with
mesenchymal cells genetically engineered to have constitutive
Hh pathway activation. The UGSM-2 cell line is an immortalized
mesenchymal cell line derived from the E16 urogenital sinus
mesenchyme (Shaw et al., 2006). These cells were transfected
with either activated Smo or Gli2 to produce constitutive ligand
independent Hh pathway activation as indicated by elevated
expression of Gli1 and Ptc1 as compared to cells transfected with
an empty vector (Fig. 2A and B). E16 UGS or P1 prostatic rudiments
were co-cultured with the transfected UGSM-2 cells for seven days
in serum free media supplemented with testosterone (Fig. 2 C, D,
E, and F). BrdU labeling was performed 2 h before tissues were
harvested and prepared for histological examination. Serial sec-
tions were co-stained for BrdU with epithelial marker PanCk/P63
and the epithelial mitotic index calculated as previously described
(Cook et al., 2007). The presence of UGSM-2 cells transfected with
activated Smo increased epithelial proliferation in the E16 UGS
tissues as compared to UGSM-2 cells transfected with an empty
vector (Fig. 3). This stimulatory effect of increased Hh signaling is
consistent with the previously reported decrease in epithelial
proliferation when the E14 UGS was cultured in the presence ofli2 OE) or Smo (Smo OE). (A,B) RT-PCR analysis demonstrates increased expression
cted with GFP alone. n Po0.05, n¼3. This conﬁrmed that transfection with Gli2 or
nsfected with GFP alone (control) or activated Smo (Smo OE) were co-cultured with
culture. Scale bar: 400 μm.
Fig. 3. Activation of paracrine Hh signaling exerts differential effects on epithelial proliferation in cultured prenatal and postnatal tissues. E16 and P1 tissues were co-
cultured with UGSM-2 cells (control or Smo OE) for 7 days. BrdU labeling was performed prior to harvest and sections were immunostained for BrdU and either PanCk or
P63. (A-B) BrdU (red) and Panck (green) co-staining on 7 day co-cultured E16 UGS tissue with UGSM-2 cells (control and Smo OE) and (C-D) BrdU (green) and P63 (red) co-
staining on 7 day cultured P1 prostatic rudiments with UGSM-2 cells (control and Smo OE). The images are representative of n¼5 tissues in each group. (E-F) Co-culture with
Smo OE cells increased epithelial proliferation in E16 UGS tissues but decreased proliferation in P1 prostatic rudiments. nPo0.05.
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of activated paracrine Hh signaling was strikingly different on the
cultured P1 prostatic rudiments. There the presence of UGSM-2
cells transfected with activated Smo decreased epithelial prolif-
eration (Fig. 3). This echoes similar ﬁndings by Wang and collea-
gues in their studies of the P2 rat UGS (Wang et al., 2003). These
gain of function studies, together with our studies of chemical
inhibition, suggest stage-speciﬁc effects of Hh signaling—stimu-
lating ductal budding and proliferation in the prenatal prostate
and decreasing ductal branching and proliferation in the postnatal
prostate.
Stage-speciﬁc regulation of Hh target genes
The transcriptional response to Hh signaling includes the
canonical target genes Ptc1, Gli1 and HIP as well as tissue and
cell-speciﬁc target genes. We have previously characterized Hh
target gene expression in the E16 urogenital sinus mesenchyme
(Yu et al., 2009). Recognizing that target gene regulation may be
inﬂuenced by the developmental stage and/or tissue microenvir-
onment, we compared the regulation of selected target genes in
the E16 UGS and P1 prostate. Isolated E16 UGS and P1 prostatic
rudiments were cultured in testosterone supplemented, serum
free media in the presence or absence of AZ75 for seven days and
RNA was prepared for RT-PCR analysis of canonical and non-
canonical target gene expression. AZ75 uniformly inhibited
expression of the canonical target genes Gli1 and Ptc1 in the
cultured explants (Fig. 4A and B), validating effective blockade of
Hh-induced target gene activation. In the cultured E16 UGS, AZ75inhibited expression of Igfbp-6, Igfbp-3, Fbn2 and Agpt4 (Fig. 4C, E,
F, and H); increased expression of Mmp13 and did not signiﬁcantly
alter FGF 5 gene expression (Fig. 4D and G). These observations
recapitulate the observed effect of cyclopamine on gene expres-
sion in the cultured E16 UGS (Yu et al., 2009). The results in the
cultured P1 prostate were quite different. AZ75 treatment
decreased Igfbp-6 and increased expression of Mmp13 (Fig. 4C
and D) as it did in early E16 explants but paradoxically increased
expression of Igfbp-3, Fbn2, Agpt4 and FGF 5 (Fig. 4E–H).
The mesenchymal and epithelial compartments of the devel-
oping prostate undergo extensive morphogenetic changes and
change in differentiation during the perinatal period. To determine
if the developmental stage of the mesenchyme determines the
proﬁle of Hh target gene expression, we compared Hh target gene
expression in freshly prepared primary mesenchymal cells from
the E16 UGS and P1 prostate tissues cultured with or without
exogenous Shh for 24 h. Shh peptide increased expression of Gli1,
Ptc1 and Igfbp-6 and decreased expression of Mmp13 in both E16
and P1 mesenchymal cells (Fig. 5). These effects mirror the
equivalent Hh-dependence of these target genes in the intact
E16 UGS and P1 prostate (above). The remaining four genes
assayed showed disparate responses (Fig. 5). Expression of Igfbp-
3, Fbn2 and Agpt4 was induced by Shh in E16 mesenchyme cells, a
ﬁnding that mirrors their positive regulation by Hh signaling in
the intact E16 UGS. This inductive effect was not observed in P1
mesenchymal cells and this suggests that the transcriptional
response to Hh ligand may vary simply with the developmental
stage or state of differentiation of the mesenchyme. However, this
cannot fully explain the disparate responses at different
Fig. 4. Discordant regulation of Hh target genes patterns in the cultured prenatal UGS and postnatal prostate. E16/ P1 tissues were cultured in vitro 7AZ75 (0.5 μM) for
7 days. Expression of Hh target genes was quantitated by RT-PCR. (A–D) Four target genes (Gli1, Ptc1, Igfbp-6 and MMP13) displayed the same response to AZ75 treatment in
both E16 UGS and P1 prostatic rudiments. AZ75 decreased expression of Gli1, Ptc1 and Igfbp-6 and increased expression of Mmp13). (E–H) Four genes exhibited discordant
responses to AZ75 in E16 UGS and P1 prostatic rudiments. AZ75 decreased expression of Igfbp-3, Fbn2 and Agpt4 in E16 UGS tissues and did not alter expression of FGF5. In
contrast, AZ75 increased expression of all four genes in P1 prostatic rudiments. nPo0.05, n¼3.
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cells did not recapitulate the negative regulation of Igfbp-3, Fbn2
and Agpt4 observed in the intact P1 prostate. Other factors such as
interaction with the epithelium or the stromal microenvironment
play a role in determining the net response to Hh signaling. This is
further suggested by the effects of Hh signaling on FGF5 expres-
sion. Identiﬁcation of FGF5 came from microarray studies per-
formed on the UGSM-2 cell line (Yu et al., 2009). FGF5 expression
is signiﬁcantly up-regulated by Shh in mesenchymal cells isolated
from the E16 UGS; it is increased but not signiﬁcantly in mesench-
ymal cells from the P1 prostate. By contrast, FGF5 is not Hh
regulated in the cultured E16 UGS but is down-regulated by Hh
signaling in the P1 prostate.
To examine the inﬂuence of dynamic interaction with the epithe-
lium on the mesenchymal target gene response to Hh signaling, we
investigated the target gene response in recombinant tissues com-
posed of epithelium and mesenchyme from different stages of
development and cultured in the presence or absence of AZ75. In
order to selectively measure mesenchymal gene expression, weutilized the mesenchyme from the mouse and epithelium from the
rat. The developmental stages used were mouse E16 UGS and the
developmental stage equivalent rat E18 UGS and both mouse and rat
P1 prostate. The expectation that recombinants of mouse mesench-
yme and rat epithelium would recapitulate the molecular interactions
of the developing mouse prostate is based upon the ﬁnding that such
recombinants grafted under the renal capsule generate normal
appearing prostate tissue with rat-derived prostate ductal epithelium
and mouse-derived stromal elements (Chung and Cunha, 1983).
Freshly separated mesenchyme and epithelium were recombined
and cultured for seven days in testosterone supplemented media in
the presence or absence of AZ75. The four tissue recombinants were:
E16 mouse mesenchyme with either E18 or P1 rat epithelium and P1
mouse mesenchyme with either E18 or P1 rat epithelium. Hh target
gene expression was assayed by RT-PCR using mouse target gene
primers (Fig. 6). Expression of the canonical target genes Gli1 and Ptc1
were strongly inhibited by AZ75 in all cultured tissue. This ﬁnding
indicates both that robust Hh signaling was re-established in the tissue
recombinants and was effectively inhibited by addition of AZ75 to the
Fig. 5. Differential regulation of Hh target genes in cultured primary mesenchymal cells from E16 and P1 tissues. Primary cells were cultured with or without exogenous Shh
(5 nM) for 24 h and expression of Hh target genes was analyzed by RT-PCR. Shh increased expression of Gli1, Ptc1 and Igfbp-6, and decreased expression of Mmp13 in both
E16 and P1 mesenchymal cells. Shh increased expression of Igfbp-3, Fbn2, FGF-5 and Agpt4 in E16 mesenchymal cells but did not signiﬁcantly alter expression in P1
mesenchymal cells. nPo0.05, n¼4.
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Igfbp3, Fbn2, FGF5 and Agpt4) showed signiﬁcantly regulated expres-
sion by Hh signaling in at least one of the recombinants. However, the
canonical patterns of Hh regulated target gene expression in the
cultured E16 UGS and P1 prostate was not recapitulated in the
cultured (M)E16m/(R)E18e and (M)P1m/(R)P1e recombinants, respec-
tively. Only Agpt4 was signiﬁcantly regulated by Hh signaling in the
cultured (M)E16m/(R)E18e recombinant. Both Igfbp3 and Agpt4 were
positively regulated by Hh signaling in the (M)P1m/(R)P1e recombi-
nant but this contrasts with their negative regulation in the mouse P1
prostate. Hh regulated expression of several target genes was observedin the heterochronic recombinants (M) E16m/(R) P1e and (M) P1m/(R)
E18e, but this was inconsistent. These ﬁndings indicate that even
though paracrine Hh signaling is re-established in the tissue recombi-
nants, canonical patterns of positive and negative target gene regula-
tion are only sporadically recapitulated in the temporally homotypic
(M)E16m/(R)E18e and (M)P1m/(R)P1e recombinants. While we cannot
discount the inﬂuence of species differences, these data suggest that
the physical disruption associated with mesenchymal–epithelial
separation and recombination perturbs stage-speciﬁc patterns of Hh
target gene regulation determined by the architecture of the devel-
oping tissue and the mesenchymal cell microenvironment.
Fig. 6. Hh target gene analysis results in cultured mouse–rat tissue recombinants with AZ75 (0.5 μM) treatment for 7 days. Mouse mesenchyme isolated at either E16
(E16mM) or P1 (P1mM) was recombined with epithelium isolated from the rat at either E18 (E18rE) or P1 (P1rE) and cultured for 7 days in testosterone-supplemented
media 7AZ75 (0.5 μM). Hh target gene expression was assayed by RT-PCR using mouse target gene primers. nPo0.05, n¼3.
M. Yu, W. Bushman / Developmental Biology 380 (2013) 87–9894Differential effect of activated paracrine Hh signaling on prenatal and
postnatal prostate growth in vivo
To examine the role of Hh signaling in regulating prostate growth
in vivo, we utilized transgenic mice in which Hh signaling was
conditionally activated in the UGS mesenchyme/prostate stroma. We
utilized transgenic mice expressing cre from a Fibroblast speciﬁc
protein-1 (Fsp1) promoter, Fsp1.cre mice, in which, cre is selectively
expressed in ﬁbroblast cells as early as embryonic day 9.5 (Bhowmick
et al., 2004; Iwano et al., 2002). When the Fsp1.cre mouse was mated
with the Rosa26 reporter mouse, there was efﬁcient recombination in
the developing prostate as shown by X-gal staining (Fig. 7B). The cre
mice were mated with the SmoM2.YFP transgenic mouse to selectively
express an activated form of Smo in the mesenchyme of the develop-
ing prostate. The progeny were viable and activated Hh signaling was
conﬁrmed by RT-PCR analysis of Gli1 and Ptc1 expression in the UGS
(Fig. 7A). BrdU labeling of the E18 UGS demonstrated increased
proliferation in the epithelium of the SmoM2:Fsp1.cre recombinant
as compared to littermate controls (Fig. 8A,B, and E). In contrast,activated Hh signaling decreased the BrdU labeling index in the ductal
epithelium of the P10 prostate (Fig. 8C,D, and F) and the P21 SmoM2:
Fsp1.cre recombinant prostate was grossly smaller. To examine the
possibility that activated Hh signaling decreased branching morpho-
genesis in the postnatal prostate, we performed quantitative micro-
dissection of the prostate lobes as previously described (Sugimura
et al., 1986). This revealed signiﬁcantly decreased number of ductal tips
in both ventral and dorsal lobes of the adult prostate in the P21
SmoM2:Fsp1.cre recombinant as compared to controls (Fig. 9). This
observation indicates that activated Hh signaling inhibits epithelial
proliferation during postnatal prostate development and that this is
associated with an impairment of branching ductal morphogenesis.Discussion
The role of Hh signaling in prostate development has been
studied by several different laboratories using a both mouse and
rat as the experimental subject and a variety of experimental
Fig. 7. Conditional activation of Hh signaling in stromal cells of SmoM2:Fsp1.cre transgenic mice. (A) RT-PCR analysis of Gli1 and Ptc1 expression in the E18 UGS from
SmoM2:Fsp1.cre transgenic mice and control littermates. Increased expression of Gli1 and Ptc1 in SmoM2:Fsp1.cre mice indicates constitutive activation of Hh signaling in
mutants. nPo0.05, n¼3. (B) X-gal staining of the P10 prostate obtained from the progeny from crossing Fsp1.cre and Rosa26 LacZ reporter mice reveals selective staining of
stromal cells (blue color). Section was counterstained with fast-red. n¼3.
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apparently inconsistent conclusions. We utilized in vitro culture of
the prenatal and postnatal mouse prostate complemented by
studies of transgenic mouse with activated mesenchymal Hh
signaling to resolve these long-standing discrepancies by showing
that Hh signaling exerts a temporal stage-speciﬁc effect on
prostate growth.
In our study, chemical inhibition of Hh signaling in cultured
E16 explants decreased the number of ductal tips while increasing
the number of ductal tips in the cultured P1 explants. This ﬁnding
suggested a stage-speciﬁc role of Hh signaling in regulation of
prostatic budding and branching. Our experiments revealed
similarly discordant effects on prostatic epithelial proliferation.
Co-culture with UGSM-2 cells transfected with activated Smo in
the cells stimulated epithelial proliferation in the E16 UGS tissues
while inhibiting proliferation in the P1 UGS tissues. In addition to
corroborating stage-speciﬁc effects on growth, this experiment
demonstrated that these differences are attributable speciﬁcally to
indirect paracrine Hh signaling. This observation is all the more
remarkable because the activated cell line, UGSM2, is the same in
both E16 and P1 cultured tissues. The altered growth effects
suggest either that the epithelial target of paracrine Hh signaling
changes with developmental stage or that the transcriptional
readout and growth effects of UGSM-2 cells is inﬂuenced by the
age of the co-cultured tissues.
Our studies of target gene expression at the different stages of
development suggest that differential regulation of target genes in
the prenatal and postnatal stages may be an important factor.
Speciﬁcally, several genes positively regulated by Hh signaling in
E16 explants displayed negative regulation in cultured P1 explants.
Stage-speciﬁc differences in target gene regulation were also
evident in primary cultured mesenchymal cells from E16 and P1.
However, these cells could not fully recapitulate the differences
seen in the cultured explants—a ﬁnding which suggests either
further factors other than the mesenchymal character at different
development stages exerts an inﬂuence. To determine the relativecontributions of the epithelium and mesenchyme to stage-speciﬁc
patterns of target gene regulation, we performed heterotypic
recombination between rat and mouse. The failure to recapitulate
the canonical patterns of regulation in the E16/E18 and P1/P1
recombinants made it impossible to interpret the cross-stage
recombinants. At the same time, this ﬁnding suggested that
physical dissociation of the tightly organized mesenchyme and
epithelium perturbs – at least temporarily – the canonical patterns
of stage-speciﬁc target gene regulation and implicated the tissue
microenvironment as a critical feature of the response to Hh
signaling.
Our transgenic mice model experiment complemented the
in vitro studies. This is the ﬁrst time, to our knowledge, that
transgenic activation of Hh signaling has been used to examine the
effect on prostate development, and corroborated our in vitro obser-
vations by demonstrating changes in growth and morphogenesis
consistent with stage-speciﬁc effects of activated Hh signaling on
growth. These studies used the ﬁbroblast speciﬁc promoter FSP1.cre
to drive a conditional activated Smo in the prostate mesenchyme/
stroma. The UGS mesenchyme and prostate stoma are both hetero-
geneous in composition, X-gal staining on prostate tissue from FSP1.
cre:Rosa26 mice indicated that cre is expressed in only a subpopula-
tion of the stromal cells. A limitation of this approach is that
conditional activation of the Hh pathway in a mesenchymal/stromal
sub-population may not faithfully recapitulate the canonical pattern
of Hh pathway activity among the heterogeneous cell population in
this tissue layer. Future studies using conditional and inducible
promoters to activate Hh signaling in selected sub-populations will
be able to parse the speciﬁc effects of these sub-populations in the
Hh-regulated growth of the prostate.
Hh signaling has been shown to exert a variety of function in
different tissues. In a study of Hh signaling function during
pancreas development, Lau showed that before E12.5, low level
of Hh signaling promotes the expansion of pancreatic epithelium.
In contrast, Hh signaling blocks the proliferation of pancreatic
epithelium at midgestation (Lau and Hebrok, 2010). In tongue
Fig. 8. Conditional transgenic activation of paracrine Hh signaling exerts stage-speciﬁc effects on epithelial proliferation. Immunostaining for BrdU and P63/Panck were
performed on parafﬁn-sectioned tissues from E18 UGS and P10 prostate removed from SmoM2:Fsp1.cre mutant and the control littermates one hour after BrdU
administration. (A,B) Representative image of E18 control UGS immunostained for BrdU (red) and P63 (green). (C,D) Representative image of control P10 prostate
immunostained for BrdU (red) and Panck (green). (E,F) Quantitative comparison of epithelial BrdU labeling index reveals an increased proliferation at E18 and a decreased
proliferation at P10 in SmoM2:Fsp1.cre mutants. nPo0.05, n¼3.
M. Yu, W. Bushman / Developmental Biology 380 (2013) 87–9896development, inhibition of the Hh signaling from early develop-
ment (E12–E14) can eliminate tongue development (E12) or alter
tongue shape (E13) or increase the number of fungiform papillae,
but disruption of Hh signaling after E16 has no effect on the
patterning of fungiform papillae (Liu et al., 2004). Temporal
regulation of Hh signaling has also been reported in forebrain
and hair follicle development as well (Oro and Higgins, 2003;
Sousa and Fishell, 2010). Our data adds to the growing evidence
that Hh signaling exerts pleiomorphic actions that are different not
only between sites in the developing embryo but also within the
same organ at different times.
The Hh target genes that were discordantly regulated pre- and
postnatally included Igfbp3, FGF5, Agpt4 and Fbn2. These are genes
reported to be involved in events of cell proliferation, vascular
angiogenesis, and extracellular matrix assembly. Noting that these
genes were positively regulated by Hh signaling prenatally and
negatively regulated postnatally, we speculate that these genes
collaborate in stimulating epithelial proliferation. FGF5 belongs to
the ﬁbroblast growth factor family and it is expressed in a complex
spatiotemporal pattern during embryogenesis (Goldfarb et al., 1991).
Its growth promoting activities were evidenced in pancreatic cancer
and brain cancer (Allerstorfer et al., 2008; Kornmann et al., 2001). Italso has been identiﬁed as an overexpressed antigen in multiple
adenocarcinomas including breast carcinoma and prostate carcinoma
(Hanada et al., 2001). Another function of FGF5 is its potential role as
an angiogenic factor (Giordano et al., 1996). Similarly, Agpt4, which
belongs to angiopoietin family, promotes angiogenesis process by
targeting speciﬁcally at endothelial cells (Lee et al., 2004). Fbn2, a
major structural component of extracellular microﬁbrils, has been
implicated in regulation of TGF-beta/BMP signaling (Ramirez et al.,
2008; Ramirez and Dietz, 2007). Igfbp3 has exhibited a complex array
of activities depending on the context (Granata et al., 2004; Massoner
et al., 2009; Silha et al., 2006). Functional studies of these genes in the
developing prostate may elucidate how their evolution in responsive-
ness to Hh signaling is linked to regulation of growth and morphogen-
esis. Interestingly, FGF5, Agpt4 and Fbn2 all exhibit positive regulation
in prostate cancer with a reactive stroma (Shaw et al., 2009).
Correlating this ﬁnding with our differential regulation results, we
postulate that during embryonic development Hh stimulates expres-
sion of these genes to promote growth and morphogenesis, inhibits
expression of these genes postnatal to down-regulate growth and
maintain tissue homeostasis, and that reiteration of positive regulation
in the tumor stroma stimulates prostate cancer cell growth (Shaw
et al., 2009).
Fig. 9. Activated paracrine Hh signaling in transgenic mice model decreased ductal tips number in both ventral prostate (VP) and dorsal prostate (DP) at postnatal P21 stage.
Prostate lobes were removed from the mutant SmoM2:Fsp1.cre mice and the control littermates at P21, followed by microdissection to count the number of ductal tips. (A,C)
control and (B,D) mutant. (E) Quantitative data of the total ductal tips number revealed a decreased ductal tips number in both VP and DP in SmoM2:Fsp1.cre mutant mice.
nPo0.05, n¼3, scale bar¼1 mm.
M. Yu, W. Bushman / Developmental Biology 380 (2013) 87–98 97In conclusion, our study demonstrates a stage-speciﬁc effect of
paracrine Hh signaling on prostate epithelial ductal growth, a
mechanism possibly mediated by discordant regulation of the
mesenchymal target genes determined by the complex interactions
in the tissue microenvironment of the developing prostate. With the
emerging evidence of the paracrine Hh signaling mechanism in
directing the tumorigenesis of the prostate, we believe that better
understanding of the paracrine Hh signaling in normal prostate
development will help elucidate its role in prostate cancer and
facilitate therapeutic targeting of the Hh pathway.Acknowledgments
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